Gimv: majority stake sold in rehaneo

(CercleFinance.com) - Gimv announced on Wednesday that it would be selling its majority stake in rehaneo, a German specialist in outpatient rehabilitation services, to the Fremman Capital fund.


The Belgian investment company points out that this transaction follows four years of support, having acquired a stake in the company in 2020, at the height of the Covid period.

In the meantime, rehaneo has succeeded in integrating 13 companies in 23 different locations, including a new center recently established in Göttingen, and now employs some 1,000 people.

The company treats over 80,000 patients every year.

The transaction, which is expected to be completed in the first quarter of 2025, should have a financial impact of around one euro per share in terms of net asset value (NAV) as at September 30, which will be announced tomorrow.

Over the entire investment period, Gimv claims to have generated a return well in excess of the long-term objective that should characterize its portfolio.

The share price rose by 1.4% following this announcement, outperforming the BEL 20 index on the Brussels stock exchange, which was up by 0.4% at the same time.

Copyright (c) 2024 CercleFinance.com. All rights reserved.